http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2714074-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00a421ab71bd49a451d0a49d23a082c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d137f8e7503ba75f6edf7cbdf54e98c7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
filingDate 2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a8de3fe216b58a1814989bebb90d352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b85f5abc57d92ea8a3f185e8782ad38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a6f2027c5e13fc4b4ad16d0b3337f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d90a7728125dc2b7694d9494b295f31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96be9bc2e3c2828f3e1591dc3e0505ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b6e5c06b9d6bf1fe2ba11dda230ca2
publicationDate 2019-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2714074-T3
titleOfInvention Mono- or disubstituted indole derivatives as inhibitors of dengue virus replication
abstract A compound of formula (I) ** Formula ** a stereoisomeric form, a pharmaceutically acceptable salt, solvate or polymorph thereof, comprising a mono- or disubstituted indole group; said compound is selected from a group where: R1 is H, R2 is F and R3 is H, F or CH3; R1 is F or CH3, R2 is OCH3 and R3 is H; R1 is F, R2 is H and R3 is CH3; R1 is H, R2 is OCH3 and R3 is H; R1 is H, R2 is Cl and R3 is H or CH3; R1 is F, R2 is F and R3 is H or R1 is CH3, R2 is H and R3 is F.
priorityDate 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467235022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467234878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468056528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467234873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468052550

Total number of triples: 34.